Search for Clinical Trial Results

Sponsored By

Burkitt Lymphoma - 25 Studies Found

Status Study
Completed Study Name: Chemotherapy Plus Rituximab Combination for Adult Lymphoblastic Leukemia (B-ALL) and Burkitt's Non-Hodgkin Lymphoma
Condition:
  • Burkitt Lymphoma
  • B-ALL

Date: 2011-02-02
Interventions: Drug: Chemotherapy-Rituximab combination Short cycles of high-dose and conventional chemotherapy in comb
Terminated Study Name: Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma
Condition:
  • Burkitt Lymphoma
  • Non-Hodgkins Lymphoma
  • Drug: Rituximab Low Risk: Intr
Completed Study Name: Rituximab Combined With Chemotherapy in Burkitt`s Lymphoma
Condition:
  • Acute Lymphoblastic Leukemia
  • Burkitt's Lymphoma

Date: 2006-10-13
Interventions: Drug: RITUXIMAB 375 mg/m2/d day 1
Completed Study Name: Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt Lymphoma
Condition:
  • HIV
  • Burkitt's Lymphoma

Date: 2012-01-06
Interventions:
  • Drug: Induction Phase

Completed Study Name: LMBA02 Protocol for Patients With a Burkitt Lymphoma
Condition: Burkitt Lymphoma
Date: 2005-09-12
Interventions: Drug: rituximab
Terminated Study Name: Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL
Condition: Burkitt Lymphoma
Date: 2005-09-12
Interventions: Drug: Rituximab
Active, not recruiting Study Name: Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma
Condition:
  • Burkitt Lymphoma
  • Diffuse Large B-cell Lymphoma, c-MYC Positive<
    Date: 2010-03-23
    Interventions:
    • Drug: EPOCH-R EPOCH-R every 21
Completed Study Name: Forodesine Hydrochloride (BCX-1777) for B-Cell Acute Lymphoblastic Leukemia
Condition: B-cell Acute Lymphoblastic Leukemia
Date: 2006-02-08
Interventions: Drug: forodesine hydrochloride (BCX-1777)
Completed Study Name: The Safety and Efficacy of CART-19 Cells in B-cell Acute Lymphoblastic Leukemia (B-ALL).
Condition: B-cell Acute Lymphoblastic Leukemia
Date: 2016-09-29
Interventions:
  • Drug: Cyclophosphamide patient
Active, not recruiting Study Name: T-Lymphocytes Genetically Targeted to the B-Cell Specific Antigen CD19 in Pediatric and Young Adult Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
Condition: Relapsed B-Cell Acute Lymphoblastic Leukemia
Date: 2013-05-21
Interventions:
  • Procedure: leukapheresis or collection of PBMCs
Next >>>